Evidence map›Paper›PMID 40592022›Full record

ArticleSocial science & medicine (1982)2025

Charting a path forward toward integrating macrolevel phenomena, marginalization, and health equity principles in into dissemination and implementation science.

Hannah Lf Cooper, Kelli Hall, Cam Escoffery, Melvin Doug Livingston, Jessica Sales, Anna Mullaney, Whitney Rice, Umed Ibragimov, Michelle Kegler, Claire Sterk and 2 more

Abstract readHistorical Article
In one paragraph

Article in Social science & medicine (1982), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hannah Lf CooperEmory University Rollins School of Public Health, United States. Electronic address: hcoope3@emory.edu.
Kelli HallColumbia University Mailman School of Public Health, United States.
Cam EscofferyEmory University Rollins School of Public Health, United States.
Melvin Doug LivingstonEmory University Rollins School of Public Health, United States.
Jessica SalesEmory University Rollins School of Public Health, United States.
Anna MullaneyEmory University Rollins School of Public Health, United States.
Whitney RiceEmory University Rollins School of Public Health, United States.
Umed IbragimovFlorida State University College of Nursing, United States.
Michelle KeglerEmory University Rollins School of Public Health, United States.
Claire SterkEmory University Rollins School of Public Health, United States.
Chandra FordEmory University Rollins School of Public Health, United States.
Lisa BowlegGeorge Washington University, United States.

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
Translational Research Core - Engagement and Behavior ChangeP30DK111024 · NIDDK · EMORY UNIVERSITY · PI Mohammed Kumail Ali · 2016 to 2026
$13.4M
The CORAL Training CoreU54HD113292 · NICHD · MOREHOUSE SCHOOL OF MEDICINE · PI Hannah LF Cooper, ANNE Lang DUNLOP · 2023 to 2026
$9.8M
Research Capacity Building CoreU54CA284036 · NCI · EMORY UNIVERSITY · PI Michael Hoonbae Chung · 2023 to 2026
$4.8M
Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE)UH3DA044798 · NIDA · UNIVERSITY OF KENTUCKY · PI COOPER, HANNAH LF, YOUNG, APRIL MARIE · 2019 to 2022
$4.4M
An implementation science study of violence screening practices among Ryan White-funded sites in the Southeastern United StatesR01MH121962 · NIMH · EMORY UNIVERSITY · PI KALOKHE, AMEETA SHIVDAS, SALES, JESSICA A · 2020 to 2024
$3.3M
Developing the evidence base for overdose policies: a multilevel analysis of NHBSR01DA046197 · NIDA · EMORY UNIVERSITY · PI COOPER, HANNAH LF · 2018 to 2022
$3.2M
Risk Environments for Pregnant/Postpartum Women who Use Drugs: a longitudinal qualitative studyR01DA058065 · NIDA · EMORY UNIVERSITY · PI Hannah LF Cooper · 2023 to 2026
$2.7M
Substance use in PRegnancy and the mOrbidity Mortality rISk Environment (PROMISE)R01DA059182 · NIDA · EMORY UNIVERSITY · PI Hannah LF Cooper, Michael Root Kramer · 2024 to 2026
$2.1M
Young Adults and Drug Use: Careers and Familiar FactorsR01DA009819 · NIDA · EMORY UNIVERSITY · PI STERK, CLAIRE E · 1996 to 2004
$1.9M
Training in Advanced Data Analytics to End Drug-Related Harms (TADA)T32DA050552 · NIDA · EMORY UNIVERSITY · PI Howard H Chang, Hannah LF Cooper · 2020 to 2026
$1.6M
Kentucky Communities & Researchers Engaging to Halt the Opioid Epidemic-CARE2HOPEUG3DA044798 · NIDA · UNIVERSITY OF KENTUCKY · PI COOPER, HANNAH LF, YOUNG, APRIL MARIE · 2017 to 2018
$1.3M
NCI NIH HHS U54 CA284036NIAID NIH HHS P30 AI050409NICHD NIH HHS U54 HD113292NIDA NIH HHS R01 DA009819NIDA NIH HHS R01 DA046197NIDA NIH HHS R01 DA058065NIDA NIH HHS R01 DA059182NIDA NIH HHS T32 DA050552NIDA NIH HHS UG3 DA044798NIDA NIH HHS UH3 DA044798NIDDK NIH HHS P30 DK111024NIMH NIH HHS R01 MH121962NIMH NIH HHS R34 MH132497
6 · The paper itself

Abstract

Dissemination and implementation (D&I) science is ascendant within public health in the United States, but D&I scientists have long voiced concern at their field's capacity to fulfill two essential and intertwined public health responsibilities: analyzing and intervening in macrosocial determinants and achieving health equity. To help break this impasse, we explore D&I's theoretical roots by critically reviewing three historical eras, eras that D&I's origin story has identified as foundational to D&I's development: 1890-1903: Tarde's Laws of Imitation. 1920-1960: Rural Sociology. 1960-1980: Knowledge Utilization Research. Our racism-conscious disciplinary self-critique reveals that, as elsewhere in public health, D&I became ascendant in part by developing an "epistemology of ignorance" that has acted in service to racial capitalism - that is, D&I has developed a structured way of (not) knowing that systematically suppresses evidence about racial capitalism and its consequences. Each of D&I's foundational eras was characterized by marked transitions in racial capitalism, in which macrosocial phenomena produced novel forms of marginalization that in turn engendered mass resistance (e.g., industrialization and imperialism; farming crises). In response, D&I's forebears crafted explanatory frameworks (e.g., Diffusion of Innovation) that obscured these transformational macrosocial phenomena, reinforced the marginalizations that they produced, and diverted attention toward atomistic individual-level phenomena. These frameworks have helped foster an epistemology of ignorance within D&I about macrosocial phenomena, marginalization, and health inequities that persists to this day. We propose that D&I has an opportunity to forge another era now in which it partners with critical social scientists, practitioners, activists, and people with lived experience to bring macrosocial phenomena, marginalization, and health inequities more firmly into its orbit. We close with principles to guide the development of this era that are rooted in learnings from D&I's history and Public Health Critical Race Praxis.

Indexed as

Health EquityImplementation ScienceInformation DisseminationPublic HealthSocial MarginalizationHistory, 20th CenturyHumansRacismUnited StatesDissemination and implementation scienceEpistemic injusticeHealth equityMacrosocialRacial capitalism

Identifiers

PMID40592022
PMCPMC12371533

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.